Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Node; Prostate × Radiosurgery × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 108 Carcinoma, Renal Cell 36 Melanoma 13 Kidney Neoplasms 13 Neoplasm Metastasis 11 Urinary Bladder Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Brain Neoplasms 9 Sarcoma 8 Lung Neoplasms 8 Prostate Cancer Metastatic 6 Neoplasms 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Prostate Adenocarcinoma 4 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Thyroid Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Oligometastatic Prostate Cancer 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphatic Metastasis 2 Local Recurrence of Malignant Tumor of Prostate 2 Colorectal Neoplasms 2 Colonic Neoplasms 2

Interventions

durvalumab 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03795207 2026-03-31

POSTCARD

Institut Cancerologie de l'Ouest

Phase 2 Active not recruiting

Node; Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡